Distinct specificities of the HEMK2 protein methyltransferase in methylation of glutamine and lysine residues
Protein Science · 2024
DOI: 10.1002/pro.4897 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, 2024. Verfasst von Sara Weirich und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Technical Biochemistry, Department of Biochemistry, University of Stuttgart, Stuttgart, Germany. Hauptthemen laut MEDLINE: Glutamine, Lysine, Site-Specific DNA-Methyltransferase (Adenine-Specific). Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, Israeli Cancer Research Foundation Israel, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
The HEMK2 protein methyltransferase has been described as glutamine methyltransferase catalyzing ERF1‐Q185me1 and lysine methyltransferase catalyzing H4K12me1. Methylation of two distinct target residues is unique for this class of enzymes. To understand the specific catalytic adaptations of HEMK2 allowing it to master this chemically challenging task, we conducted a detailed investigation of the substrate sequence specificities of HEMK2 for Q‐ and K‐methylation. Our data show that HEMK2 prefers methylation of Q over K at peptide and protein level. Moreover, the ERF1 sequence is strongly preferred as substrate over the H4K12 sequence. With peptide SPOT array methylation experiments, we show that Q‐methylation preferentially occurs in a G‐ Q ‐X 3 ‐R context, while K‐methylation prefers S/T at the first position of the motif. Based on this, we identified novel HEMK2 K‐methylation peptide substrates with sequences taken from human proteins which are methylated with high activity. Since H4K12 methylation by HEMK2 was very low, other protein lysine methyltransferases were examined for their ability to methylate the H4K12 site. We show that SETD6 has a high H4K12me1 methylation activity (about 1000‐times stronger than HEMK2) and this enzyme is mainly responsible for H4K12me1 in DU145 prostate cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry and Technical Biochemistry, Department of Biochemistry, University of Stuttgart, Stuttgart, Germany.
- The Shraga Segal Department of Microbiology, Immunology and Genetics, Ben-Gurion University of the Negev, Be'er-Sheva, Israel.
- The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Be'er-Sheva, Israel.
ORCID-Profile: Albert Jeltsch
Förderung
- Israel Science Foundation
- Israeli Cancer Research Foundation Israel
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Weirich, S., Ulu, G. T., Chandrasekaran, T. T., Kehl, J., Schmid, J., Dorscht, F., Kublanovsky, M., Levy, D., & Jeltsch, A. (2024). Distinct specificities of the HEMK2 protein methyltransferase in methylation of glutamine and lysine residues. Protein Science. https://doi.org/10.1002/pro.4897
Vancouver
Weirich S, Ulu GT, Chandrasekaran TT, Kehl J, Schmid J, Dorscht F, et al. Distinct specificities of the HEMK2 protein methyltransferase in methylation of glutamine and lysine residues. Protein Science. 2024. doi:10.1002/pro.4897
BibTeX
@article{Weirich2024,
author = {Weirich, Sara and Ulu, Gizem T and Chandrasekaran, Thyagarajan T and Kehl, Jana and Schmid, Jasmin and Dorscht, Franziska and Kublanovsky, Margarita and Levy, Dan and Jeltsch, Albert},
title = {Distinct specificities of the HEMK2 protein methyltransferase in methylation of glutamine and lysine residues},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.4897}
}
EUVIMED